Chugai Applies For Bactrimin Approval
This article was originally published in PharmAsia News
Executive Summary
Chugai Pharmaceutical Co. Ltd Feb. 13 applied for a new indication of pneumocystis pneumonia for Bactrimin (trimethoprim/sulfamethoxazole) in Japan.